The Asian Scientist 100
Xi Dai
Institution
Hong Kong University of Science and Technology
Country
Hong Kong
Field
Physics
Dai received the 2025 Future Science Prize in Physical Science for pioneering contributions to condensed matter physics and topological materials, including predicting novel quantum states and enabling their experimental realization, advancing next-generation electronic and quantum technologies.
(Photo: The Future Science Prize Foundation)
AWARDS
- 2025 Future Science Prize in Physical Science
Related articles
Eating Fruit Daily Reduces Risk Of Heart Attacks
A study of half a million people in China has found that just 100 grams of fruit per day can cut the risk of cardiovascular mortality by a third.
This Gene Helps Plants “Breathe” At Night
In plants, the AOR gene protects against toxic byproducts of nighttime respiration—and could be used to help plants grow in stressful environments.
Moby-Dick And Lessons In Science Writing
Literature classics like Moby-Dick bring the natural world to life in vivid, beautiful and haunting ways. What if these novels were co-taught by literature and biology professors?
China’s Salty Problem
Although salt consumption in China has decreased since 2002, it remains above the maximum recommended daily intake.
Light, G-Proteins, Action! The Script For Optical Nerve Healing
The combination of light-activated neuronal activity and enhanced G-protein signaling has been shown to help re-grow damaged axons in mice.
Babies Can Categorize Colors Before Learning What They’re Called
Researchers have found that babies can differentiate between color categories even before learning language.
Sanofi & Hanmi To Partner On New Diabetes Drugs
The Sanofi-Hanmi deal centers around longer-lasting biologics, which could reduce the frequency of treatment and dosage required for diabetic patients.
Tiny Seaweed Beads Could One Day Replace Insulin Injections
Microfluidics could help make pancreatic islet transplants more effective for patients with type 1 diabetes.
Generic Hepatitis Drug Launched In India As Hepcvir
Generics manufacturer Cipla has been granted the license to produce Sofosbuvir in India under the brand name Hepcvir.